Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 6,482 | 4,227 | 6,151 | 1,683 | 0 |
| Cost of Goods | 5,133 | 4,055 | 4,329 | 1,207 | N/A |
| Gross Profit | 1,349 | 172 | 1,822 | 476 | N/A |
| Operating Expenses | 52,394 | 111,285 | 86,931 | 55,044 | 48,567 |
| Operating Income | -50,912 | -111,058 | -84,780 | -54,361 | -48,567 |
| Other Income | -424 | -2,484 | 2,676 | -15,992 | 488 |
| Pre-tax Income | -51,336 | -113,542 | -82,104 | -70,353 | -48,079 |
| Income Tax | -182 | N/A | N/A | -1,830 | N/A |
| Net Income Continuous | -51,154 | -113,542 | -82,104 | -68,523 | -48,079 |
| Net Income Discontinuous | 139 | -47,812 | -50,634 | N/A | N/A |
| Net Income | $-51,015 | $-161,354 | $-132,738 | $-68,523 | $-48,079 |
| EPS Basic Total Ops | -1.20 | -3.90 | -4.03 | -2.44 | -2.25 |
| EPS Basic Continuous Ops | -1.20 | -2.75 | -2.49 | -2.44 | -2.25 |
| EPS Basic Discontinuous Ops | 0.00 | -1.16 | -1.54 | N/A | N/A |
| EPS Diluted Total Ops | -1.20 | -3.90 | -4.03 | -2.44 | -2.25 |
| EPS Diluted Continuous Ops | -1.20 | -2.75 | -2.49 | -2.44 | -2.25 |
| EPS Diluted Discontinuous Ops | 0.00 | -1.16 | -1.54 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-49,588 | $-86,145 | $-82,901 | $-53,959 | $-48,447 |